Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting

Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional ...
The Journal

FDA grants conditional approval for New World screwworm drug

On Sept. 30, the U.S. Food and Drug Administration conditionally approved the first injectable drug for the prevention and treatment of New World screwworm in cattle. The drug is produced by Zoetis ...
American BankerOpinion

De novo national banks face a new road map to OCC approval

Conditional approval of a national bank charter used to be a virtual guarantee that an institution would open its doors. But ...